HealthcareServices

Global Pulmonary Embolism Industry Insights: Key Trends and Growth Estimates

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pulmonary embolism market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Pulmonary Embolism Market be in 2030 compared with 2026?

The pulmonary embolism market has experienced rapid expansion in recent years. It is projected to increase from $2.26 billion in 2025 to $2.53 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.0%. This historical growth can be attributed to a rise in cardiovascular and thromboembolic disorders, the expansion of hospital emergency care services, broader adoption of anticoagulant medications, increased understanding of pulmonary embolism symptoms, and the availability of sophisticated diagnostic imaging.

The pulmonary embolism market is anticipated to experience significant expansion over the next few years. It is projected to reach $4.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.1%. This growth during the forecast period can be ascribed to escalating investments in advanced anticoagulant drugs, the increasing uptake of catheter-based intervention techniques, the broadening of early diagnostic screening programs, a heightened focus on outpatient management strategies, and the rising demand for personalized cardiovascular care. Prominent trends for the forecast period include the increasing adoption of novel anticoagulant therapies, a growing utilization of minimally invasive thrombectomy devices, an intensified focus on early and accurate diagnosis, the expansion of integrated care pathways, and a stronger emphasis on risk stratification and prevention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13026&type=smp

What Drivers Are Guiding Growth Patterns In The Pulmonary Embolism Market?

The rising incidence of cancer is projected to boost the expansion of the pulmonary embolism market. Cancer encompasses various diseases marked by the uncontrolled and abnormal multiplication of cells within the body. A higher prevalence of cancer elevates the risk of blood clot formation, such as pulmonary embolism, in patients. This, in turn, fuels the demand for diagnostic tools and therapeutic solutions, including specialized pharmaceuticals. As an example, the American Cancer Society reported in January 2024 that the number of cancer cases in the US climbed to 2,001,140 from 1,958,310 in 2023, showing a 2.19% increase. Consequently, the growing prevalence of cancer is a significant factor driving the pulmonary embolism market’s growth.

How Is The Pulmonary Embolism Market Divided Into Segments?

The pulmonary embolism market covered in this report is segmented –

1) By Treatment: Medications, Mechanical Devices, Other Treatments

2) By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis

3) By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Medications: Anticoagulants, Thrombolytics

2) By Mechanical Devices: Inferior Vena Cava (IVC) Filters, Catheter-Assisted Thrombectomy

3) By Other Treatments: Surgical Embolectomy, Supportive Care

Which Market Trends Are Opening Growth Opportunities In The Pulmonary Embolism Market?

Leading companies within the pulmonary embolism market are prioritizing the development of advanced products, such as the Triever16 Curve catheter and the RevCore thrombectomy catheter, to secure a competitive edge. For example, Inari Medical Inc., a US-based medical device company, introduced both the Triever16 Curve catheter and the RevCore thrombectomy catheter in June 2023. The innovative Triever16 Curve catheter is specifically engineered for peripheral thrombectomy and pulmonary embolism procedures, offering high trackability and a pre-shaped curve for focused aspiration. Its unique design also enables easy access to larger, more powerful 20F or 24F catheters. Concurrently, the RevCore thrombectomy catheter is devised for treating venous in-stent thrombosis, functioning as a mechanical thrombectomy device that utilizes a nitinol basket to capture and remove blood clots. Ultimately, these catheters are also instrumental in improving the safety and effectiveness of pulmonary embolism procedures.

Which Major Industry Participants Are Leading The Pulmonary Embolism Market Growth?

Major companies operating in the pulmonary embolism market are Pfizer Inc., Johnson And Johnson Private Limited, F Hoffmann La Roche Ltd., Merck And Co Inc., Novartis AG, Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, GSK plc, Abbott Laboratories, AstraZeneca plc, Medtronic plc, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Mitsubishi Tanabe Pharma Corporation, Genentech Inc., Hikma Pharmaceuticals plc, Aspen Pharmacare Holdings Limited, Nippon Shinyaku Co. Ltd., Fresenius Kabi AG, Inari Medical Inc., AngioDynamics Inc., Otsuka Pharmaceutical Co. Ltd., CSL Behring GmbH, Grifols S.A., Octapharma AG, Kedrion S.p.A

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Pulmonary Embolism Market?

North America was the largest region in the pulmonary embolism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pulmonary embolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pulmonary Embolism Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13026&type=smp

Browse Through More Reports Similar to the Global Pulmonary Embolism Market 2026, By The Business Research Company

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Vascular Embolization Market Report 2026

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

Venous Thromboembolism Market Report 2026

https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795